XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Note 3 - Stock-based Compensation
6 Months Ended
Jan. 01, 2023
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

Note 3 Stock-Based Compensation

 

The Company has a Long Term Incentive and Share Award Plan, which is more fully described in Note 12 and Note 13 to the consolidated financial statements included in the Companys Annual Report on Form 10-K for the fiscal year ended July 3, 2022, that provides for the grant to eligible employees, consultants and directors of stock options, restricted shares, and other stock-based awards.

 

The amounts of stock-based compensation expense recognized in the periods presented are as follows:

 

  

Three Months Ended

  

Six Months Ended

 
  

January 1,

2023

  

December

26, 2021

  

January 1,

2023

  

December

26, 2021

 
  

(in thousands)

 

Stock options

 $593  $9  $593  $18 

Restricted stock

  1,306   2,282   2,861   5,278 

Total

  1,899   2,291   3,454   5,296 

Deferred income tax benefit

  465   565   846   1,306 

Stock-based compensation expense, net

 $1,434  $1,726  $2,608  $3,990 

 

Stock-based compensation is recorded within the following line items of operating expenses:

 

  

Three Months Ended

  

Six Months Ended

 
  

January 1,

2023

  

December

26, 2021

  

January 1,

2023

  

December

26, 2021

 
  

(in thousands)

 

Marketing and sales

 $874  $1,006  $1,574  $2,333 

Technology and development

  152   91   307   211 

General and administrative

  873   1,194   1,573   2,752 

Total

 $1,899  $2,291  $3,454  $5,296 

 

 

Stock-based compensation expense has not been allocated between business segments, but is reflected as part of Corporate overhead (see Note 12 - Business Segments). 

 

Stock Options

 

The following table summarizes stock option activity during the six months ended January 1, 2023:

 

  

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value

 
          

(in years)

  

(in thousands)

 

Outstanding at July 3, 2022

  -  $-         

Granted

  2,346,416  $8.59         

Exercised

  -  $-         

Forfeited

  -   -         

Outstanding at January 1, 2023

  2,346,416  $8.59   9.9  $2,276 
                 

Exercisable at January 1, 2023

  -  $-   -  $- 

 

As of January 1, 2023, the total future compensation cost related to non-vested options, not yet recognized in the statement of income, was $11.4 million and the weighted average period over which these awards are expected to be recognized was 2.9 years.

 

Restricted Stock

 

The Company grants shares of Common Stock to its employees that are subject to restrictions on transfer and risk of forfeiture until fulfillment of applicable service and performance conditions and, in certain cases, holding periods (Restricted Stock). The following table summarizes the activity of non-vested restricted stock awards during the six months ended January 1, 2023:

 

  

Shares

  

Weighted

Average Grant

Date Fair

Value

 

Non-vested at July 3, 2022

  929,709  $21.82 

Granted

  717,799  $8.38 

Vested

  (368,249) $17.68 

Forfeited

  (37,903

)

 $21.30 

Non-vested at January 1, 2023

  1,241,356  $15.29 

 

The fair value of non-vested shares is determined based on the closing stock price on the grant date. As of January 1, 2023, there was $13.7 million of total unrecognized compensation cost related to non-vested, restricted, stock-based compensation to be recognized over the weighted-average remaining period of 2.9 years.